Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment

Results from this study demonstrate that Tanzania’s national guidelines—which forbid malaria diagnosis through RDT or microscopy in the “private retail sector”—may be unnecessarily curbing testing and treatment rates, given the high proportion of patients seeking private sector care.

Author: , , , , , , , , , , ,
Publication date: January 2017
Source: Malaria Journal

The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015

This article, published in Nature found that Plasmodium falciparum infection prevalence in endemic Africa halved and the incidence of clinical disease fell by 40% between 2000 and 2015. Interventions have averted an estimated 663 (542–753 credible interval) million clinical cases since 2000. Insecticide-treated nets, the most widespread intervention, were by far the largest contributor (68% of cases averted).

Author: , , , , , , , , , , , , , , , , , , , , , , , , , ,
Publication date: September 2015
Source: Nature

An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa.

This article outlines some of the barriers to single low-dose (SLD) primaquine use to stop P. falciparum transmission. In-country key informants revealed that the WHO weight-based recommendation to use SLD primaquine is challenging to implement in actual field settings, due in part to safety concerns involving G6PD deficiency and drug-drug interactions, among other factors.

Author: , , , , , , , ,
Publication date: May 2015
Source: Malaria Journal